Showing results (11-20 of 114) with videos related to
Sort By:
Pageof 12
Frontiers in Pharmacology|May 31, 2019
Theranostics in Interventional Oncology: Versatile Carriers for Diagnosis and Targeted Image-Guided Minimally Invasive ProceduresNils Degrauwe, Arnaud Hocquelet, Antonia Digklia, et al.Frontiers in Immunology|October 15, 2019
Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the TumorsChakradhar Yakkala, Cheryl Lai-Lai Chiang, Lana Kandalaft, et al.Radiographics : a Review Publication of the Radiological Society of North America, Inc|September 15, 2012
Multidetector CT features of mesenteric vein thrombosisRafael Duran, Alban L Denys, Igor Letovanec, et al.European Journal of Radiology|October 8, 2019
Characteristics of patients treated for active lower gastrointestinal bleeding detected by CT angiography: Interventional radiology versus surgeryMegan Pannatier, Rafael Duran, Alban Denys, et al.Expert Review of Anticancer Therapy|November 6, 2014
Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRIJulius Chapiro, MingDe Lin, Rafael Duran, et al.Frontiers in Oncology|November 17, 2022
Tumor response assessment on imaging following immunotherapyAntonia M Berz, Clarisse Dromain, Naïk Vietti-Violi, et al.Frontiers in Pediatrics|February 21, 2024
Case Report: Transcatheter interventional procedure to innominate vein turn-down procedure for failing fontan circulationDamien Schaffner, Maria-Helena Perez, Rafael Duran, et al.Diagnostic and Interventional Imaging|August 22, 2021
Image-guided marking techniques in interventional radiology: A review of current evidenceGeorgia Tsoumakidou, Sarah Saltiel, Nicolas Villard, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 16, 2017
Drug-eluting embolic microspheres for local drug delivery - State of the artKatrin Fuchs, Rafael Duran, Alban Denys, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2024
Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma ModelChakradhar Yakkala, Jesus Corria-Osorio, Lana Kandalaft, et al.Pageof 12